Thermo Fisher Scientific Announces Extension of Tender Offer for Olink Shares and ADSs

Thermo Fisher Scientific, a global leader in serving science, has made a strategic move to extend its tender offer for the acquisition of all outstanding common shares and American Depository Shares (ADSs) of Olink. This development is of particular interest to investors and market watchers alike, considering the potential impact on both companies' future growth and financial performance.

Details of the Tender Offer Extension

The tender offer, which was previously set to expire, has now been officially prolonged. Thermo Fisher announced that the expiration of the offer is now scheduled for 5:00 p.m., New York Time, on December 14, 2023. This extension provides additional time for shareholders of Olink to tender their shares and ADSs as part of the acquisition process.

Investor Considerations

Investors holding stock in Thermo Fisher Scientific or shares and ADSs of Olink are advised to consider the implications of the extended offer. The tender offer is a critical step for Thermo Fisher in its strategy to expand its portfolio of diagnostics and life sciences solutions, and could potentially influence the stock performance of both entities. For investors tracking stock ticker symbols, the relevant symbols to monitor are TMO for Thermo Fisher Scientific and OLK for Olink.

Investment, Acquisition, Extension